DMCRN-02-001: Assessing Pediatric Endpoints in DM1 | MicrobiomeTrials← Back to trialsNCT05224778
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
RecruitingOBSERVATIONAL
Trial Details
Start: 2022-08-24Est. Completion: 2026-10
Enrollment target: 50 participants Locations- University of California, Los Angeles, Los Angeles, California, United States
- University of Kansas Medical Center, Fairway, Kansas, United States
- University of Rochester Medical Center, Rochester, New York, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- Centro Clinico NeMO, Milan, Italy
Other microbiome trials you might be interested in
Myotonic Dystrophy 1DM1
Building on previous work of the Myotonic Dystrophy Clinical Research Network (DMCRN), the present study seeks to overco…
La Jolla, United StatesEst. completion Oct 1, 2026
Myotonic Dystrophy Type 1 (DM1)
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of VX-670 at di…
San Carlos, United StatesEst. completion Feb 2, 2027